Avior Wealth Management LLC Grows Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Avior Wealth Management LLC increased its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 38.2% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 11,824 shares of the company's stock after buying an additional 3,270 shares during the period. Avior Wealth Management LLC's holdings in Prestige Consumer Healthcare were worth $1,017,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare in the 4th quarter valued at about $84,932,000. Raymond James Financial Inc. purchased a new stake in Prestige Consumer Healthcare in the fourth quarter valued at approximately $42,593,000. Norges Bank bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at approximately $40,009,000. Bessemer Group Inc. lifted its position in Prestige Consumer Healthcare by 10,053.1% during the fourth quarter. Bessemer Group Inc. now owns 295,050 shares of the company's stock valued at $23,041,000 after purchasing an additional 292,144 shares during the last quarter. Finally, Natixis Advisors LLC grew its stake in Prestige Consumer Healthcare by 1,335.1% in the 4th quarter. Natixis Advisors LLC now owns 209,246 shares of the company's stock worth $16,340,000 after buying an additional 194,665 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Trading Down 3.3%

Shares of PBH stock traded down $2.77 on Wednesday, hitting $81.90. 351,110 shares of the company's stock traded hands, compared to its average volume of 299,594. The stock has a market capitalization of $4.05 billion, a price-to-earnings ratio of 19.09, a P/E/G ratio of 2.54 and a beta of 0.45. The company's fifty day simple moving average is $84.06 and its 200 day simple moving average is $82.50. Prestige Consumer Healthcare Inc. has a one year low of $64.94 and a one year high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.82 and a current ratio of 4.20.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The firm had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the firm earned $1.02 earnings per share. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on PBH. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.